ProCAncer-I: a H2020-funded project aimed at developing a platform to support clinical decision making in prostate cancer through medical imaging and AI

Published on: October 29, 2020
Categories: News

The Medical Imaging Research Group at IDIBGI will receive funding to carry out the ProCAncer-I project starting late 2020. The project has been recently approved by the European Commission and will be funded under the H2020 framework program.

Highlights

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices were discussed at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24). The congress took place from the 7th to 10th of November 2024...

Stay in touch!